mild-to-moderate systemic lupus erythematosus
Conditions
Interventions
Treatment Group:treated with prednisone and Jieduquyuzishen recipe
control group:treated with prednisone
Sponsors
Zhejinag University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Complying with four or more items in the SLE western medicine diagnosis standard; the patients accord with liver-kidney Yin deficiency toxic heat and blood stasis; the SLE patients in mild- moderate period (SLEDAI between 5 to 14); patients in the age between 18 and 60 years; patients who voluntary to enjoy the test and agree to sign informed consent certificates; patients did not use other related drugs within one week before experimental treatment.
Exclusion criteria
Exclusion criteria: The illness in severe active period; current dosage of prednisone >1mg/kg.d; merge use other immunosuppressive agents beyond glucocorticoid; merge of the fatal damage to target organs; pregnant and lactating women and mental patients; can't tolerate the durgs of the study; diagnosesed as type VI of lupus nephritis or phase V of Chronic nephrosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| dosage of prednisone;SLEDAI;Blood routine;Stool routine;Urine routine;Blood biochemistry parameter; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndromes scores;SF-36;AE; | — |
Countries
China
Contacts
Public ContactFan Yongsheng
Outcome results
None listed